Global Oncology Drugs Market Report By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Other Cancers) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Oncology Drugs Market Report
Brand: Value Market Research
SKU: Pharmaceuticals
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11213665

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Oncology Drugs Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028. Whereas with regards to volume, the market was calculated XX Kilo Tons in 2021 and foreseen to touch XX Kilo Tons by 2028 with a CAGR of XX% during 2022-2028.

Oncology drugs refer to medications used for cancer treatment. A drug used in cancer treatment varies in structure and mechanism of action. It kills cancer cells, stops them from growing and spreading to other parts of the body, helps the body regain strength, and develop new healthy cells. It also treats symptoms that cancer causes, like pain. With advances in understanding cancer biology, better treatment options, including drugs, are being devised, leading to new products approval and launch.

Market Dynamics

The growing burden of cancer diseases drives the growth of the global oncology drugs market. According to the World Health Organization estimates, the worldwide cancer burden is assessed to have ascended to 18.1 million new cases, and 9.6 million passings in 2018. It is projected that by 2030 between 10 and 11 million cancers will be diagnosed each year in low- and middle-income countries. The expanding disease burden is because of a few elements, including the aging population, changing lifestyle, among others. The growing approval for new drugs by the FDA and rising penetration of health insurance is amplifying revenue growth. Malignant of the lung, female breast, and colorectum are the top three cancers in terms of incidence, estimated to hold the majority share in global terms. However, expensive treatment and limited treatment options restrain the growth of the market.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of oncology drugs.

Market Segmentation

The entire oncology drugs market has been sub-categorized into drug class type and indication. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Drug Class Type

Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy

By Indication

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for oncology drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Oncology Drugs Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the oncology drugs market include AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, f. Hoffmann-La Roche ltd., Johnson & Johnson (Janssen Global Services, LLC), Merck & Co., Inc., Novartis AG, Pfizer Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Oncology Drugs Market
       2.2. Global Oncology Drugs Market Snapshot

3 . ONCOLOGY DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Oncology Drugs Market
       3.3. Market Restraints of Oncology Drugs Market
       3.4. Opportunities of Oncology Drugs Market
       3.5. Trends of Oncology Drugs Market
       3.6. Porter’s Five Force Analysis of Oncology Drugs Market
       3.7. Oncology Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Class Type
           3.7.2 Market Attractive Analysis by Indication
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Oncology Drugs Value Chain Analysis
       4.2. Oncology Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Oncology Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Oncology Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Oncology Drugs Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Oncology Drugs Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Oncology Drugs Market
       5.5. COVID-19: Micro and Macro Factor Analysis on Oncology Drugs Market

6 . GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY DRUG CLASS TYPE
       6.1 Overview by Drug Class Type
       6.2 Historical Data 2016-2019
       6.3 Global Oncology Drugs Market Analysis by Drug Class Type
       6.4 Market Analysis of Chemotherapy by Regions
       6.6 Market Analysis of Targeted Therapy by Regions
       6.5 Market Analysis of Immunotherapy (Biologic Therapy) by Regions
       6.7 Market Analysis of Hormonal Therapy by Regions

7 . GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Historical Data 2016-2019
       7.3 Global Oncology Drugs Market Analysis by Indication
       7.4 Market Analysis of Lung Cancer by Regions
       7.5 Market Analysis of Stomach Cancer by Regions
       7.6 Market Analysis of Colorectal Cancer by Regions
       7.7 Market Analysis of Breast Cancer by Regions
       7.8 Market Analysis of Prostate Cancer by Regions
       7.9 Market Analysis of Liver Cancer by Regions
       7.10. Market Analysis of Esophagus Cancer by Regions
       7.11 Market Analysis of Cervical Cancer by Regions
       7.12 Market Analysis of Kidney Cancer by Regions
       7.13 Market Analysis of Bladder Cancer by Regions
       7.14 Market Analysis of Other Cancers by Regions

8 . GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview and Historic Data
           8.3.2. North America Oncology Drugs Market Estimate By Market Segment
           8.3.3. North America Oncology Drugs Market Estimate By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview and Historic Data
           8.4.2. Europe Oncology Drugs Market Estimate by Market Segment
           8.4.3. Europe Oncology Drugs Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview and Historic Data
           8.5.2. Asia Pacific Oncology Drugs Market Estimate by Market Segment
           8.5.3. Asia Pacific Oncology Drugs Market Estimate by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview and Historic Data
           8.6.2. Latin America Oncology Drugs Market Estimate by Market Segment
           8.6.3. Latin America Oncology Drugs Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Argentina
         8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview and Historic Data
           8.7.2. Middle East & Africa Oncology Drugs Market Estimate by Market Segment
           8.7.3. Middle East & Africa Oncology Drugs Market Estimate by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE ONCOLOGY DRUGS COMPANIES
       9.1. Oncology Drugs Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF ONCOLOGY DRUGS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. AbbVie Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Astellas Pharma Inc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. AstraZeneca PLC
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Bristol-Myers Squibb Company
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Celgene Corporation
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. f. Hoffmann-La Roche ltd.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Johnson & Johnson (Janssen Global Services, LLC,)
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Merck & Co., Inc.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Novartis AG
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Pfizer Inc..
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Oncology Drugs Report
Market Research Process
Market Research Methodology
Global Oncology Drugs Market Size, by Region
Porters Five Forces Analysis
Market Attractiveness Analysis by Drug Class Type
Market Attractiveness Analysis by Indication
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Oncology Drugs Market Analysis by Drug Class Type
Global Oncology Drugs Market Analysis in Chemotherapy by Region
Global Oncology Drugs Market Analysis in Targeted Therapy by Region
Global Oncology Drugs Market Analysis in Immunotherapy (Biologic Therapy) by Region
Global Oncology Drugs Market Analysis in Hormonal Therapy by Region
Global Oncology Drugs Market Analysis by Indication
Global Oncology Drugs Market Analysis in Lung Cancer by Region
Global Oncology Drugs Market Analysis in Stomach Cancer by Region
Global Oncology Drugs Market Analysis in Colorectal Cancer by Region
Global Oncology Drugs Market Analysis in Breast Cancer by Region
Global Oncology Drugs Market Analysis in Prostate Cancer by Region
Global Oncology Drugs Market Analysis in Liver Cancer by Region
Global Oncology Drugs Market Analysis in Esophagus Cancer by Region
Global Oncology Drugs Market by Volume And Revenue
North America Oncology Drugs Market by Volume And Revenue
Europe Oncology Drugs Market by Volume And Revenue
Asia Pacific Oncology Drugs Market by Volume And Revenue
Latin America Oncology Drugs Market by Volume And Revenue
Middle East & Africa Oncology Drugs Market by Volume And Revenue
Recent Development in Oncology Drugs Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "